Recent advances in gene therapy for bone tissue engineering


Autografting, a major treatment for bone fractures, has potential risks related to the required surgery and disease transmission. Bone morphogenetic proteins (BMPs) are the most common osteogenic factors used for bone-healing applications. However, BMP delivery can have shortcomings such as a short half-life and the high cost of manufacturing the recombinant proteins. Gene delivery methods have demonstrated promising alternative strategies for producing BMPs or other osteogenic factors using engineered cells. These approaches can also enable temporal overexpression and local production of the therapeutic genes in the target tissues. This review addresses recent progress on engineered viral, non-viral, and RNA-mediated gene delivery systems that are being used for bone repair and regeneration. Advances in clustered regularly interspaced short palindromic repeats/Cas9 genome engineering for bone tissue regeneration also is discussed. © 2022 John Wiley & Sons Ltd.

Authors Ranjbarnejad F, Khazaei M, Shahryari A, Khazaei F, Rezakhani L
Journal Journal of tissue engineering and regenerative medicine
Publication Date 2022 Dec;16(12):1121-1137
PubMed 36382408
DOI 10.1002/term.3363

Research Projects

Cell Lines